Thomas Richard Kassberg - Sep 30, 2021 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
CBO & EVP
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Sep 30, 2021
Transactions value $
$34,018
Form type
4
Date filed
10/1/2021, 12:57 PM
Previous filing
May 10, 2021
Next filing
Oct 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Options Exercise $34K +110K +102.73% $0.31* 217K Sep 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RARE Stock Option (Right to Buy) Options Exercise $0 -110K -100% $0.00* 0 Sep 30, 2021 Common Stock 110K $0.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F2 The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date.